US EditionPublished • loading... • Updated
Akebia Therapeutics to Conduct Investor Meetings at the Raymond James 2026 Biotech Innovation ...
Summary by Hastings Tribune
2 Articles
2 Articles
Akebia Therapeutics to Conduct Investor Meetings at the Raymond James 2026 Biotech Innovation ...
CAMBRIDGE, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive Officer, Erik Ostrowski,…
·Nebraska, United States
Read Full Article
Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium
WALTHAM, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the…
Coverage Details
Total News Sources2
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
